John Marshall Bancorp stock gains on buyback extension

John Marshall Bancorp (JMSB) and Eagle Financial Services agreed to merge in an all-stock deal valued at $253M. Eagle shareholders will receive 2 JMSB shares per Eagle share, a ~11.5% premium. The combined entity will have $4.4B in assets and trade on Nasdaq as JMSB. Post-merger, JMSB plans to increase its quarterly dividend to $0.155 per share.

Eagle Financial Services (EFSI) is being acquired by John Marshall Bancorp (JMBI) in an all-stock deal valued at $253M. The merger will create a $4.4B company with 23 banking offices. EFSI shareholders will receive 2 JMBI shares for each EFSI share, representing an 11.5% premium. The transaction is expected to close in Q1 2027, subject to regulatory and shareholder approvals.

John Marshall Bancorp, Inc. (JMSB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 jmsb-20260722xex99d1.htm EX-99.1 Exhibit 99.1 For Immediate Release July 22, 2026 ​ Strong Loan Growth and Sustained Net Interest Margin Expansion Drive 1.20% Return on Average Assets and 10.34% Return on Average Equity ​ Reston, VA – John Marshall Bancorp, Inc. (Nasdaq

Truist Financial (TFC) agreed to sell $5.5 billion in auto loans, generating $5.2 billion in net proceeds. The sale is part of CEO Mike Lyons' strategy to exit less profitable businesses. Truist is also reviewing its securities portfolio to offset the capital impact. Analysts expect further divestitures as the bank aims for stronger growth and profitability.

Oracle is conducting global job cuts, with affected employees notified on September 14. The company increased its restructuring costs by $700M to $2.8B. Employees and families shared emotional accounts of sudden layoffs on social media. India may be significantly impacted, with reports suggesting thousands of job losses. Oracle's workforce reduced by 21,000 in fiscal 2026. The company did not comment on the reports.

Abbott Laboratories will pay $385 million to settle U.S. and state allegations regarding manufacturing practices at its Michigan and Arizona facilities from 2018 to 2022, according to the DOJ. The settlement resolves claims of false submissions to government programs due to alleged contamination risks and inadequate testing. Abbott will pay $348.7 million to the federal government and $36.3 million to states. Three whistleblowers will receive $69 million.